Feb 9Microvascular Therapeutics selected as a Participant in the 2024 Landmark Venture ForumMicrovascular Therapeutics selected as a Participant in the 2024 Landmark Venture Forum [Tucson, AZ] – Microvascular Therapeutics Inc....
Feb 8Microvascular Therapeutics welcomes Thom Tulip as Chief Business Officer[Tucson, Arizona] – [2/05/2024] – Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing...
Dec 12, 2023Microvascular Therapeutics Selected as a Participant in the 2023 H7 BioCapital Accelerator ProgramMicrovascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has...
Dec 12, 2023Breakthrough Study by Microvascular Therapeutics Reveals Fibrin-Targeted Phase Shift Microbubbles asMicrovascular Therapeutics, a trailblazing healthcare research and development company, announces a groundbreaking study on the treatment...